"Vector" Spoke About Vaccination With "EpiVacCorona" In The Presence Of Antibodies

"Vector" Spoke About Vaccination With "EpiVacCorona" In The Presence Of Antibodies
"Vector" Spoke About Vaccination With "EpiVacCorona" In The Presence Of Antibodies

Video: "Vector" Spoke About Vaccination With "EpiVacCorona" In The Presence Of Antibodies

Отличия серверных жестких дисков от десктопных
Video: EULAR PARE Webinar COVID-19 registries and vaccination 2023, January
Anonim

MOSCOW, January 19 - RIA Novosti. The presence of antibodies to coronavirus is not a contraindication for vaccination with the drug EpiVacCorona, it can strengthen the existing immunity, RIA Novosti was told in the press service of Rospotrebnadzor, citing the response of the Vector scientific center.

"The presence of antibodies is not an obstacle to immunization with the EpiVacCorona peptide vaccine, which in this case can strengthen the existing immunity," the message says.

The Rospotrebnadzor also reminded that the decision on vaccination is made by the doctor, after the illness, the person needs to recover and get stronger, therefore, it is necessary to vaccinate after consulting a doctor.

In August, the Russian Ministry of Health registered the world's first vaccine for the prevention of COVID-19, developed by the Gamaleya Research Center for Electrochemistry. It was named "Sputnik V". The vaccine is based on a well-studied and validated human adenoviral vector platform, the important benefits of which are safety, efficacy and no long-term adverse effects.

Later, the development of the "Vector" center of Rospotrebnadzor - "EpiVacCorona" was registered. The vaccine is characterized by areactogenicity and the highest safety.

The latest data on the situation with COVID-19 in Russia and the world are presented on the stopcoronavirus.ru portal.

Popular by topic